Advertisement

Clinical Use of Intravenous Gadolinium-DTPA in Magnetic Resonance Imaging of the Central Nervous System

  • G. M. Bydder
  • H. P. Niendorf
  • I. R. Young

Abstract

Following extensive pharmacological and animal studies (Weinmann and Grier 1983; Weinmann et al. 1984), clinical trials with intravenous gadolinium-DTPA (Gd-DTPA) were begun at the end of 1983 (Shorner et al. 1984). During 1984 one group in Berlin (Claussen et al. 1985; Felix et al. 1984a, b) and another in London (Carr et al. 1984a, b; Graif et al., to be published; Curati et al., to be published; Bydder et al. 1985) conducted clinical trials. During 1985 Gd-DTPA was released more widely and now over 20 groups in Europe and four in the United States are involved in clinical evaluation programmes. Gd-DTPA is the first parenteral magnetic contrast agent available for clinical use and the results of these clinical trials have been followed with considerable interest.

Keywords

Contrast Agent Contrast Enhancement Comput Assist Spin Echo Acoustic Neuroma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bilaniuk LT, Zimmerman RA, Spagnoli M, Goldberg HI (1985) MRI of meningiomas. Proceedings of the 4th Meeting of the Society of Magnetic Resonance in Medicine. SMRM, Berkeley, CA, p 312.Google Scholar
  2. Bradley WG, Waluch V, Yadley RA, Wycoff RR (1984) Comparison of CT and MR in 400 patients with suspected disease of the brain and cervical spinal cord. Radiology 152: 695–702.PubMedGoogle Scholar
  3. Brasch RC (1983) Methods of contrast enhancement for NMR imaging and potential applications. Radiology 147: 781–788.PubMedGoogle Scholar
  4. Bydder GM, Kingsley DPE, Brown J, Niendorf HP, Young IR (1985) MRI of meningiomas (including studies with and without Gadolinium-DTPA) J Comput Assist Tomogr 9(4): 690–697.PubMedCrossRefGoogle Scholar
  5. Bydder GM, Brown J, Niendorf HP, Young IR (to be published) Enhancement of cervical intraspinal tumours with intravenous gadolinium-DTPA. J Comput Assist Tomogr.Google Scholar
  6. Carr DH, Brown J, Bydder GM et al. (1984a) Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet I: 484–486.CrossRefGoogle Scholar
  7. Carr DH, Brown J, Bydder GM et al. (1984b) Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR 143: 215–224.PubMedGoogle Scholar
  8. Claussen C, Laniado M, Kazner E, Schorner W, Felix R (1985) Application of contrast agents in CT and MRI (NMR): their potential in imaging of brain tumours. Neuroradiology 27: 164–171.PubMedCrossRefGoogle Scholar
  9. Curati WL, Graif M, Kingsley DPE et al. (to be published) Magnetic resonance imaging: contrast enhancement of acoustic neuromas with intravenous gadolinium-DTPA. Radiology.Google Scholar
  10. Felix R, Laniado M, Claussen C, Schorner W, Weinmann HJ, Niendorf HP (1984a) Characterization of gadolinium-DTPA. Basic properties and first clinical results. 7th CARVAT, Rome, 6–10 Feb 1984.Google Scholar
  11. Felix R, Schorner W, Claussen C, Regler W, Niendorf HP (1984b) Diagnostic value of gadolinium-DTPA in MR imaging of brain tumours. Radiology 153(P): 84.Google Scholar
  12. Gadian DG, Payne JA, Bryant DJ, Young IR, Carr DH, Bydder GM (1985) Gadolinium-DTPA as a contrast agent in MRI — theoretical projections and practical observations. J Comput Assist Tomogr 9(2): 242–251.PubMedCrossRefGoogle Scholar
  13. Graif M, Bydder GM, Steiner RE, Niendorf HP, Thomas DGT, Young IR (to be published) Contrast enhanced MRI of malignant brain tumours. AJNR and AJR.Google Scholar
  14. Koenig SH, Brown RD III (to be published) Relaxation of solvent protons by paramagnetic ions and its dependence on magnetic field and chemical environment: implications for NMR imaging. Magn Reson Med.Google Scholar
  15. Koenig SH, Baglin C, Brown RD III, Brewer CF (to be published) Magnetic field dependence of solvent proton relaxation induced by Gd3+ and Mn2+ complexes. Magn Reson Med.Google Scholar
  16. Leung AW-L, Steiner RE, Young IR (1984) NMR imaging of the liver in two cases of iron overload. J Comput Assist Tomogr 8(3): 446–449.PubMedCrossRefGoogle Scholar
  17. McKay IM, Bydder GM, Young IR (in press) MRI of central nervous system tumours which do not display evidence of an increase in T1 or T2. J Comput Assist Tomogr.Google Scholar
  18. Runge VM, Clanton JA, Lukehart CM, Partain CL, James AE (1983) Paramagnetic agents for contrast enhanced NMR imaging: a review. AJR: 1209–1215.Google Scholar
  19. Schorner W, Felix R, Laniado M et al. (1984) Prüfung des kernspintomographischen Kontrastmittels Gadolinium-DTPA am Menschen. Fortschr Roengenstr 140: 495–500.Google Scholar
  20. Tripathi A, Bydder GM, Hughes JMB et al. (1984) Effect of oxygen tension on NMR spin-lattice relaxation rate of blood in vivo. Invest Radiol 19(3): 174–178.PubMedGoogle Scholar
  21. Weinmann H-J, Grier H (1983) Paramagnetic contrast media in NMR tomography — basic properties and experimental studies in animals. Proceedings of the 2nd Meeting of the Society of Magnetic Resonance in Medicine. SMRM, Berkeley, CA, pp 370–371.Google Scholar
  22. Weinmann H-J, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142: 619–624.PubMedGoogle Scholar
  23. Zimmerman RD (1984) MRI in intracranial meningiomas. Proceedings of the 3rd Meeting of the Society of Magnetic Resonance in Medicine. SMRM, Berkeley, CA, pp 779–780.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • G. M. Bydder
  • H. P. Niendorf
  • I. R. Young

There are no affiliations available

Personalised recommendations